DVN:NYSEDevon Energy Corporation Analysis
Data as of 2026-05-24 - not real-time
$47.22
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Devon Energy (DVN) sits in a bullish technical environment – the price is trading just above its 20‑day and 50‑day moving averages, while the 200‑day average remains well below, suggesting an upward bias. The RSI hovers in the mid‑40s, indicating room for upside before overbought conditions emerge, and the MACD histogram is negative, hinting at lingering bearish momentum that could reverse as price consolidates above support. Volatility is elevated at over 40% for the past month, and the beta is unusually low (near zero), implying limited correlation with broader market swings. On the fundamentals side, DVN’s forward PE of under 9× and a trailing PE of roughly 13× are well below the industry average of 21×, while the dividend yield of 2.2% is supported by a modest payout ratio and strong free cash flow generation. Analysts project a median target near $62, translating to roughly 28% upside from the current price, and the consensus recommendation is a strong buy. Recent earnings showed a sharp revenue decline and a GAAP EPS miss, but the company announced a new capital‑return program, reinforcing its commitment to shareholders.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above short‑term SMAs indicating bullish bias
- Recent earnings miss and decreasing volume suggest caution
- Support level near $44 provides a downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Valuation gap: forward PE under 9× versus industry 21×
- Upside potential of ~28% to analyst median target
- Sustainable dividend with low payout ratio and strong cash flow
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Diversified U.S. basin portfolio reduces geographic concentration
- Ongoing capital return program and dividend growth
- Energy sector cyclicality balanced by low beta and solid balance sheet
Key Metrics & Analysis
Financial Health
Revenue Growth-0.80%
Profit Margin14.17%
P/E Ratio13.2
ROE15.18%
ROA6.07%
Debt/Equity56.40
P/B Ratio1.9
Op. Cash Flow$6.4B
Free Cash Flow$1.6B
Industry P/E21.6
Technical Analysis
TrendBullish
RSI46.6
Support$44.20
Resistance$51.95
MA 20$48.49
MA 50$48.26
MA 200$39.70
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair Value$12.05
Target Price$60.56
Upside/Downside28.25%
GradeUndervalued
TypeBlend
Dividend Yield2.20%
Risk Assessment
Beta-0.23
Volatility42.53%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.